Last update 29 Jun 2024

Mufemilast

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(S)-N-(5-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-4,6-dioxo-5,6-dihydro-4H-thieno[3,4-c]pyrrol-1-yl)acetamide, HEMAY 005, HEMAY-005
+ [1]
Target
Mechanism
PDE4 inhibitors(Phosphodieterase 4 inhibitors)
Inactive Indication-
Drug Highest PhaseNDA/BLA
First Approval Date-
RegulationOrphan Drug (US), Special Review Project (CN)

Structure

Molecular FormulaC20H22N2O7S2
InChIKeyPRSNGWLHNWGOKD-CQSZACIVSA-N
CAS Registry1255909-03-5

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plaque psoriasisNDA/BLA
CN
24 Apr 2024
Behcet SyndromePhase 3
CN
16 Oct 2023
Dermatitis, AtopicPhase 2
CN
05 Jan 2023
Ulcerative colitis, active severePhase 2
CN
08 Nov 2022
Ankylosing SpondylitisPhase 2
CN
05 Aug 2022
PsoriasisPhase 1
CN
01 Dec 2016
Pulmonary Disease, Chronic ObstructiveIND Approval
CN
30 Jun 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
-
90
mcbpkafiyz(pjngoihdaf) = vguoeogkff foginvnpie (rngutpycyl )
Positive
14 Nov 2023
Not Applicable
-
szvusakqyn(bqtzmlgkfe) = sktjownesl nkcidmcdxb (pnujqxtorq )
-
13 Nov 2023
Placebo
szvusakqyn(bqtzmlgkfe) = hmjvavoqoe nkcidmcdxb (pnujqxtorq )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free